Insider · CIK 0001853723
Sr One Capital Management, LLC
Files at ADRX (ADARx Pharmaceuticals, Inc.). First filing Sep 29, 2026, latest Sep 29, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ADRX: ADARx Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | ADARx Pharmaceuticals, Inc. | $27M 1,600,000 shares | +32% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Common Stockindirect: See Note 2 | +3,334,938 | - | - | 3,334,938 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Common Stockindirect: See Note 2 | +1,113,666 | - | - | 4,448,604 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Common Stockindirect: See Note 2 | +512,897 | - | - | 4,961,501 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: See Note 2 | +592,593 | $17.00 | $10M | 5,554,094 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Common Stockindirect: See Note 3 | +1,538,691 | - | - | 1,538,691 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: See Note 3 | +414,814 | $17.00 | $7.1M | 1,953,505 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Common Stockindirect: See Note 4 | +1,667,468 | - | - | 1,667,468 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Common Stockindirect: See Note 4 | +169,001 | - | - | 1,836,469 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | POpen-market purchase Common Stockindirect: See Note 5 | +592,593 | $17.00 | $10M | 592,593 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Series B Preferred Stockderivativeindirect: See Note 2 | -3,907,547 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Series B-1 Preferred Stockderivativeindirect: See Note 2 | -1,304,883 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Series C Preferred Stockderivativeindirect: See Note 2 | -600,962 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Series C Preferred Stockderivativeindirect: See Note 3 | -1,802,885 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Series B Preferred Stockderivativeindirect: See Note 4 | -1,953,773 | $0.00 | $0 | 0 | 13 d ago |
| Sep 28, 2026 | ADRX ADARx Pharmaceuticals, Inc. | CConversion Series B-1 Preferred Stockderivativeindirect: See Note 4 | -198,019 | $0.00 | $0 | 0 | 13 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.